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ABSTRACT The kinetics of Ca21-dependent conformational changes of human cardiac troponin (cTn) were studied on isolated
cTn and within the sarcomeric environment of myoﬁbrils. Human cTnC was selectively labeled on cysteine 84 with N-((2-
(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole and reconstituted with cTnI and cTnT to the cTn complex,
whichwas incorporated into guinea pig cardiacmyoﬁbrils. These exchangedmyoﬁbrils, or the isolated cTn, were rapidlymixed in a
stopped-ﬂow apparatus with different [Ca21] or the Ca21-buffer 1,2-Bis(2-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid to
determine the kinetics of the switch-on or switch-off, respectively, of cTn. Activation ofmyoﬁbrils with high [Ca21] (pCa4.6) induced
a biphasic ﬂuorescence increasewith rate constants of.2000 s1 and;330 s1, respectively. At low [Ca21] (pCa 6.6), the slower
rate was reduced to;25 s1, but was still;50-fold higher than the rate constant of Ca21-induced myoﬁbrillar force development
measured in amechanical setup.Decreasing [Ca21] frompCa5.0–7.9 inducedaﬂuorescencedecaywith a rate constant of 39 s1,
whichwas approximately ﬁvefold faster than force relaxation.Modeling the data indicates two sequentially coupled conformational
changesof cTnC inmyoﬁbrils: 1), rapidCa21-binding (kB120mM1 s1) anddissociation (kD550s1); and2), slower switch-on
(kon¼ 390s1) and switch-off (koff¼ 36s1) kinetics. At high [Ca21],;90% of cTnC is switched on. Both switch-on and switch-off
kinetics of incorporated cTn were around fourfold faster than those of isolated cTn. In conclusion, the switch kinetics of cTn
are sensitively changed by its structural integration in the sarcomere and directly rate-limit neither cardiac myoﬁbrillar contraction
nor relaxation.
INTRODUCTION
Ca21 activation of cardiac contraction is regulated by the
human cardiac troponin complex (cTn), consisting of the
Ca21-binding cTnC subunit, the inhibitory cTnI subunit and
the tropomyosin (Tm)-binding cTnT subunit. During the
systole, cytosolic [Ca21] rises to$1mMand binds to the low
afﬁnity Ca21-binding site II of cTnC, the so-called regulatory
binding site. This leads to a conformational change of the
N-terminal domain of cTnC, which rearranges its interaction
with the C-terminal regulatory region of cTnI (1). This struc-
tural rearrangement involves the C-terminal part and the in-
hibitory region of cTnI and leads to the removal of Tm from its
blocking position on actin, allowingmyosin to bind to actin in
a force-generatingmanner. During the diastole, cytosolic Ca21
falls to submicromolar concentrations. The systolic process is
reversed: Ca21 dissociation from cTnC induces a conforma-
tional rearrangement of the complex involving cTnI and
cTnT, which immobilizes Tm on the thin ﬁlament (2). In this
way, Tm prevents myosin from binding de novo to actin in a
force-generating manner, and as the remaining cross-bridges
detach, the heart relaxes (3).
Simultaneous measurements of force and intracellular
[Ca21] in intact cardiac trabeculae have shown that the rate
of myoplasmic Ca21 increase/removal does not rate-limit force
development/relaxation (4,5). Thus, in principle, two mech-
anisms could determine the time course of the contraction/
relaxation of myocardial force: 1), the cross-bridge turnover
kinetics, and 2), the kinetics of thin-ﬁlament activation/
inactivation after Ca21 binding/dissociation.
Cross-bridge kinetics during activation/relaxation have been
obtained from force transients induced either by ﬂash pho-
tolysis of caged Ca21 and caged-Ca21 chelators in skinned
cardiac ﬁbers (6–9) or by rapidly changing the [Ca21] in the
environment of subcellular cardiac myoﬁbrils (10,11). The
observed rates of force increase/decrease and their dependence
on interventions affecting cross-bridge mechanics indicated
that cross-bridge turnover kinetics determine the time course
of cardiac myoﬁbrillar force development and relaxation. This
implies, but does not prove, that the switch-on and switch-off
kinetics of cTn are rapid processes compared to the time
course of force changes.
Kinetics of thin ﬁlament activation/inactivation have been
investigated extensively by measuring the Ca21-induced con-
formational changes of cTn using isolated regulatory proteins
like cTnC (e.g., (12–14)), or the whole cTn complex (15), as
well as more complex systems, like reconstituted thin ﬁlaments
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(16,17). Comparison of the kinetics observed with isolated
cTnC, cTnCcTnI, cTn complex, and the cTn complex in
reconstituted thin ﬁlaments showed that the kinetics depends
on the complexity of the system (15,17). However, it had not
yet been determined whether and how switch-on and switch-
off kinetics of cTn are altered when the complex is
incorporated into the functional environment of the contrac-
tile sarcomere. Therefore, direct measurements of the switch
kinetics in the sarcomere are required to test for the possible
role of cTn in rate-limiting force development/relaxation.
Recently, Bell et al. (9) measured simultaneously the
kinetics of the switch-on of cTnC and force development in
skinned ﬁbers. Ca21 activation was induced by ﬂash pho-
tolysis of caged Ca21 and switch-on kinetics was monitored
with ﬂuorescence polarization. Their ﬂuorescence polarization
signal was biphasic, which provided evidence for two confor-
mational changes. The fast conformational change (;120 s1)
was too fast to rate-limit the contraction of the cardiac mus-
cle, whereas the slow conformational change (;5 s1) had
the same rate constant as the kinetics of the force develop-
ment. The fast change was interpreted to reﬂect the kinetics
of Ca21 binding to cTnC, though it was considerably slower
than that measured for cTnC in solution. The slow change
was interpreted to reﬂect a further activation of the thin ﬁl-
ament when cross-bridges bind to it. However, it remained
unclear whether the slow phase is a consequence of cross-
bridge binding or represents an intrinsic part of thin ﬁlament
activation that rate-limits the force increase. Thus, there is a
need for an alternative technique to probe the Ca21-induced
thin ﬁlament activation in the sarcomere.
Furthermore, to fully understand the mechanism of cTn
switch in the sarcomere, not only the kinetics of the switch-on
but also that of the switch-off and its relation to force
relaxation has to be determined. Such experiments are difﬁ-
cult to perform with skinned ﬁbers because the Ca21 afﬁnity
of available caged-Ca21 chelators is limited (18). These prob-
lems can be overcome with myoﬁbrils, which are functional
contractile units of muscle. In comparison to skinned ﬁbers,
they are small enough to perform kinetic studies by rapid-
mixing techniques such as stopped-ﬂow (19,20) and rapid-
solution-change techniques (10,21). These two techniques
allow rapid and deﬁned changes from initial to ﬁnal [Ca21]
by the use of Ca21 chelators such as 1,2-Bis(2-aminophen-
oxy)ethane-N,N,N9,N9-tetraacetic acid (BAPTA).
The main goal of this study was to elucidate whether the
Ca21-dependent conformational change of cTn rate-limits the
kinetics of muscle contraction and relaxation. To determine
the kinetics of conformational change of cTn, we labeled
cTnC on Cys-84 with N-((2-(iodoacetoxy)ethyl)-N-methyl)
amino-7-nitrobenz-2-oxa-1,3-diazole (IANBD), a ﬂuorescence
detector of protein conformational changes, and reconstituted
it with cTnI and cTnT to form a heterotrimeric cTn complex
(cTn labeled with IANBD at cysteine 84 cTnC (NBD-cTn)).
NBD-cTn was then exchanged against the endogenous cTn
in cardiac myoﬁbrils. The stopped-ﬂow technique allowed us
to determine the switch-on and switch-off kinetics from the
changes in NBD-Tn ﬂuorescence, which occur after rapid
increases and decreases in [Ca21]. Because this technique
can be applied in the same way to myoﬁbrils and isolated
proteins, it allowed us to investigate how the myoﬁbrillar
environment changes switch-on and switch-off kinetics.
In parallel to the stopped-ﬂow measurements, myoﬁbrillar
force kinetics after rapid increase and decrease in [Ca21]
were measured to test whether the kinetics of force devel-
opment and/or relaxation could be rate-limited by the Ca21-
dependent conformational changes of cTn.
METHODS
Expression, ﬂuorescence-labeling and
reconstitution of human cardiac troponin
The three human cardiac troponin (cTn) subunits cTnC, cTnT, and cTnI were
separately expressed in Escherichia coli and isolated as described previously
by Kruger et al. (22), with the modiﬁcation of adding protease inhibitors
(1 mM PMSF, 1 mg/ml pepstatin A, 0.5 mM 4-(2-aminoethyl)benzenesulfonyl
ﬂuoride hydrochloride, 10mM leupeptin, 14.5mMantipain, 5mg/ml aprotinin)
to the buffer for the lysis of E. coli cells. The plasmids of the three subunits
were kindly provided by C. S. Redwood (University of Oxford, Oxford,
UK). Site-directed mutagenesis of Cys-35-Ser on cTnC allowed us to label
speciﬁcally the remaining Cys-84 in cTnC with the ﬂuorescent dye IANBD.
cTnC (2.5 mg/ml) was dissolved for 2 h at 4C in urea buffer containing 25
mM MOPS (3-(N-morpholino)propanesulfonic acid, 4-morpholinepropane-
sulfonic acid), 0.2 M NaCl, 6 M urea, 0.5 mM CaCl2, 2 mM dithiothreitol
(DTT), adjusted to pH 7.0 with NaOH, and then dialyzed (1:100) against
buffer A but with 0.1 mMDTT for;3 h. IANBD was dissolved in dimethyl-
formamide ([DMF] , 2%) and then added in a 5:1 molar ratio (IANBD/
cTnC) to the protein solution. The mixture was incubated for 1 h at 4C in
the dark. The labeling reaction was stopped by adding ;10 mM DTT. The
labeled cTnC was then dialyzed (1:100 at 4C for 2 h) against the same urea
buffer containing 1 mM DTT to remove the free ﬂuorescence label.
Thereafter the labeled cTnC was reconstituted with cTnI and cTnT to the
cTn complex, as described previously by Kruger et al. (22). Brieﬂy, for
reconstitution, the cTn subunits (weight ratio of cTnC/cTnT/cTnI ¼ 2.5:1:1)
were dialyzed in a series of buffers containing 25 mM MOPS, 0.5 mM
CaCl2, and 1 mM DTT, adjusted to pH 7.0 with NaOH and decreasing in
[NaCl] (buffer I, 1.0 M NaCl; buffer II, 0.75 M NaCl; buffer III, 0.5 M
NaCl), with a ﬁnal buffer (IV) containing 0.3 M KCl and no NaCl. Dialysis
was performed three times in each buffer for 2 h respectively. After re-
constitution, 20 mM DTT was added and the cTn solution was ﬁltered (pore
size 0.45 mm). The ﬁltrate was then stored at 80C. Before use, the cTn
solution was thawed and then dialyzed (1:10 for 1 h at 4C) against Ca21-
free rigor buffer containing 10 mM Tris, 132 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 1 mM NaN3, and 5 mM EGTA (pH 7.1 with NaOH).
Preparation of cardiac myoﬁbrils
Guinea pigs (females of 1–4.5 months in age) were anaesthetized with
isoﬂuran before the heartwas excised. The following stepswere all carried out
at 4C. The heart (1.7–2.2 g inweight) was perfused for;10 hwith the Ca21-
free rigor buffer. The ventricular walls were dissected into small pieces of
;10 mm3 and homogenized in exchange buffer (100 mg/ml) for 5 s with a
blender (Ultra-Turrax T25, Janke & Kunkel, Staufen, Germany). The homog-
enate was ﬁltrated with meshes (pore sizes 40 mm and 20 mm), and then
centrifuged (3803 g for 10 min at 4C). The pellets were resuspended in an
equal volume of a skinning buffer that contained 1% Triton X-100, 10 mM
Tris, 10mMNaCl, 15 0mMKCl, 1mMNaN3, 1mMMgCl2, and 5mMEGTA,
adjustedwithNaOH to pH7.1.After incubation for 5min, themyoﬁbrilswere
centrifuged (3803 g for 10 min at 4C) and the supernatant was discarded.
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Incorporation of NBD-cTn into myoﬁbrils
NBD-cTn was incorporated into myoﬁbrils by replacing the endogenous
cTn as a whole in the myoﬁbrils according to the technique developed by
Brenner et al. (23). To exchange the endogenous cTn in the myoﬁbrils
against NBD-cTn, the myoﬁbril pellet was resuspended in Ca21-free rigor
buffer including protease inhibitors (0.5 mM 4-(2-aminoethyl)benzenesul-
fonyl ﬂuoride hydrochloride, 10mM leupeptin, 14.5mMantipain, and 5mg/ml
aprotinin) and 1 mg/ml of NBD-cTn. The mixture was shaken gently for 1 h
at room temperature. To prevent overcontraction of the myoﬁbrils after
transferring them from the Ca21-free rigor buffer (0 mM ATP) to the ATP-
containing relaxation buffer, 10 mM of the actomyosin ATPase inhibitor
BDM (2,3-butandione-2-monoxime) was added before centrifugation of the
myoﬁbrils (380 3 g for 10 min at 4C). The pellet was then resuspended in
approximately three volumes of one of two relaxation buffers. For switch-on
kinetics, the buffer (single-mixed (SX) relaxation buffer, pCa.8) contained
10 mM imidazole, 3 mM MgCl2, 47.7 mM Na2CrP, 1 mM ATP, 3 mM
BAPTA, and 20 mM DTT, adjusted to pH 7.0 with HCl plus 10 mM BDM.
For switch-off kinetics, the buffer (double-mixed (DX) relaxation buffer,
pCa .8) had the same constitution, but with 0.6 mM BAPTA instead of
3 mM BAPTA. The myoﬁbrils were then washed twice by centrifugation
(380 3 g for 10 min at 4C) and resuspension in the respective relaxation
buffer containing no BDM to remove the excess cTn and the BDM.
To obtain myoﬁbrillar suspensions with a reproducible density of the
myoﬁbrils, the concentration of myosin heads was determined at their ab-
sorption maximum at ;280 nm as in Herrmann et al. (24). For switch-on
kinetics (single mixing) the concentration of myosin heads was 3 mM, and
for switch-off kinetics (double mixing) it was 6 mM.
The incorporation of NBD-cTn into myoﬁbrils was monitored by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). There-
fore, samples of the myoﬁbrils (;10 mg total protein/slot) before and after
the exchange were reduced with 30 mM DTT and alkylated with 75 mM
iodoacetamide at pH 8.5, according to the procedure of Lane et al. (25). The
samples were then transferred to Laemmli buffer, and the proteins were sep-
arated on a 12.5% SDS-PAGE and were visualized by Commassie-R250-
staining. The different mobility of guinea pig and human cTnI made it possible
to monitor the loss of endogenous guinea pig cTn and its replacement by the
exogenous NBD-cTn.
Stopped-ﬂow measurements
The Ca21-dependent ﬂuorescence change of cTn was measured using a
stopped-ﬂow apparatus of Bio-Logic (Claix, France) model SFM-400/S
equipped with a TC 100/10F-cuvette (10-mm light path, dead time of 2.2 ms
at 14 ml/s ﬂow rate). The sample was excited by a 75-W Hg-Xe-Lamp
(Hamamatsu, Hamamatsu, Japan) coupled to a monochromator (TgK Sci-
entiﬁc, Bradford-on-Avon, UK) set to 482 nm and a band-with of ;18 nm.
Emission of ﬂuorescencewasmonitored using anOG515nmcut-off ﬁlter and
a 530/40-nm band-pass ﬁlter in front of a custom-made photomultiplier
system. All measurements were performed at 10C. To determine the switch-
on kinetics, myoﬁbrils in SX relaxation buffer (pCa.8) were mixed 1:1 with
SX activation buffer (like relaxation buffer but containing, in addition,
different [CaCl2] up to 6mM) using the single-mixingmode of the apparatus.
The switch-off kinetics were determined by DX: myoﬁbrils in DX relaxation
buffer were ﬁrst mixed 1:1 with DX activation buffer (like DX relaxation
buffer, but with 1.2 mMCaCl2) to induce Ca
21 activation of the myoﬁbrils at
pCa5.0.After an incubation time of 91ms, themyoﬁbrilswere thenmixed 1:1
with DX inactivation buffer (like DX relaxation buffer, but with 12 mM
Na2BAPTA), which leads to an instantaneous drop in [Ca
21] to pCa.8.
To determine the kinetics of the ﬂuorescence change after mixing rigor-
myoﬁbrils with 1 mM ATP, exchanged myoﬁbrils were washed twice by
centrifugation (380 3 g for 10 min at 4C) and resuspension with normal
rigor buffer (as detailed above, but adjusted to pH 7.0 with HCl). These
myoﬁbrils were mixed 1:1 with rigor buffer containing 2 mMATP using the
single-mixing mode of the apparatus.
To determine the switch kinetics on isolated cTn, the procedure was exactly
the same as for cTn inmyoﬁbrils, except that instead ofmyoﬁbrilsweused cTn.
Before the measurements of the switch-on and -off kinetics cTn was dialyzed
1:10 against the respective relaxation buffer three times (1 h at 4C). For
switch-on and -off kinetics, the concentration of cTn was 75 mg/ml in the
cuvette.
Measurements of myoﬁbrillar force kinetics
Thin cardiac myoﬁbril bundles (2.0–3.5 mm in diameter, 25–70 mm in
length) with the incorporated NBD-cTn were mounted in an apparatus based
on the principle of atomic force microscopy, as described previously by
Stehle et al. (26). The myoﬁbrils had slack sarcomere lengths of 1.966 0.05
mm (mean6 SD), which is similar to that of native cardiac myoﬁbrils (1.98
6 0.04 mm). Bundles were prestretched by 15% of their slack length and
then Ca21-activated and thereafter relaxed by fast solution changes (10–30 ms),
based on a technique used by Colomo et al. (27). Experiments were per-
formed at 10C. Activating or relaxing buffers were the same as for stopped-
ﬂow measurements.
Statistics and data analysis
For stopped-ﬂow measurements with isolated cTn, typically three to four
traces were averaged, and for incorporated cTn, typically four to eight traces
were averaged. The averaged signals were then ﬁtted by a monoexponential
function with Biokine 32 (version V4.27, Bio-Logic, Mundelein, IL). The
obtained parameters were analyzed and modeled with GraphPad-Prism
(version 4.02), BioKine (version 4.41), and Berkeley Madonna (version 8.0.1).
Kinetic parameters of myoﬁbrillar contraction (kACT) and relaxation
(kLIN, tLIN, and kREL) were obtained as described previously (26). Transients
of force relaxation were ﬁtted to a function consisting of a linear (kLIN, tLIN)
and an exponential term (kREL), starting at the time of Ca
21 removal.
If not otherwise speciﬁed, parameters are indicated as mean 6 SE.
RESULTS
Incorporation of labeled cTn into
cardiac myoﬁbrils
The NBD-cTn was incorporated to the myoﬁbrils according
to the method developed by Brenner et al. for skinned ﬁbers
(23), i.e., by replacing the endogenous cTn as a whole com-
plex with the exogenous labeled NBD-cTn. The binding of
NBD-cTn in the sarcomere after performing the cTn ex-
change was visualized by ﬂuorescence microscopy. To test
whether NBD-cTn had been bound to the actin and not to the
myosin ﬁlaments, a myoﬁbril was mounted in the mechan-
ical setup and stretched to sarcomere length of 3.15 6 0.05
mm. Thereby the actin ﬁlaments were pulled out partly from
their overlap with the myosin ﬁlaments. Comparison of the
ﬂuorescence with the corresponding bright-ﬁeld image (Fig.
1 A) shows that the ﬂuorescence is preferentially localized
along the I-band and the distal parts of the A-band. This ﬂuo-
rescence pattern suggests that NBD-cTn is predominantly
bound to the actin ﬁlaments.
The exchange was probed by SDS-PAGE. Since endog-
enous guinea pig cTnI and exogenous human cTnI have dif-
ferent electrophoretic mobilities, they can be fully separated
by SDS-PAGE and their amounts quantiﬁed. The gel showed
that ;68 6 14% (SD, n ¼ 6) of the endogenous cTnI was
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replaced by the exogenously added NBD-cTn (Fig. 1 B). The
efﬁciency of our exchange correlates well with the exchange
described for cardiac ﬁbers (9,28,29). That the exchange is
incomplete can be explained by the fact that under rigor con-
ditions, in the absence of Ca21, mainly the overlapping region
is exchanged but not the nonoverlapping thin ﬁlament (30).
To test to what extent changes in NBD-Tn ﬂuorescence
induced by mixing myoﬁbrils with the activator Ca21 reﬂect
speciﬁcally rather than unspeciﬁcally bound NBD-Tn, the
ﬂuorescent NBD-cTn in exchanged myoﬁbrils was ‘‘chased’’
by incubating the myoﬁbrils for 1 h in Ca21-free rigor buffer
with an excess (10 mg/ml) of unlabeled cTn. The myoﬁbrils
were then mixed in the stopped-ﬂow apparatus with (pCa
4.6) or without Ca21 (pCa .8), respectively. The recorded
ﬂuorescence traces were compared with those obtained with
‘‘unchased’’ myoﬁbrils treated in the same way as the chased
ones but without adding the unlabeled cTn to the Ca21-free
rigor buffer. Fig. 1 D shows that mixing of unchased myoﬁ-
brils with Ca21 induces an exponential ﬂuorescence increase
with a signal/noise ratio of .10. In comparison to the un-
chased myoﬁbrils, chased myoﬁbrils also exhibit a signiﬁ-
cant background ﬂuorescence at pCa .8, suggesting that
some of the NBD-cTn might be not speciﬁcally bound to the
sarcomere and cannot reversibly be replaced by competitive
binding of the unlabeled cTn. However, in contrast to un-
chased myoﬁbrils, there was almost no change in ﬂuores-
cence when the chased myoﬁbrils were mixed with Ca21.
Thus, it is possible that NBD-cTn partly binds unspeciﬁcally,
but if so, this does not appear to bias the interpretation of the
ﬂuorescence signal, as it seems not to signiﬁcantly contribute
to the Ca21-induced ﬂuorescence changes.
Effect of cTn exchange and the stopped-ﬂow
technique on the myoﬁbrillar structure
We have investigated whether the exchange of cTn impairs
myoﬁbrillar structure by examining myoﬁbrils before and
after the exchange by phase contrast microscopy under 5003
magniﬁcation. We could detect no effect of exchange on
either sarcomere length or other characteristics of myoﬁ-
brillar morphology (Fig. 1 C).
To test whether the exchange of the endogenous cTn in
myoﬁbrils by the human, recombinant NBC-cTn affects the
contractile properties of myoﬁbrils, we determined the kinetic
parameters of force development and relaxation for NBD-cTn
exchanged myoﬁbrils and compared them with the param-
eters of native myoﬁbrils which were treated as exchanged
myoﬁbrils but without NBD-cTn. In both exchanged and
native myoﬁbrils, Ca21 induces a monoexponential force
development with a rate constant kACT. The values of kACT
were not signiﬁcantly different between the two preparations
(Table 1). In both preparations, Ca21 removal induced a
biphasic force decay described by an initial slow, seemingly
linear decline with a rate constant, kLIN, lasting for a dura-
tion, tLIN, followed by a rapid exponential decay with a rate
constant kREL. There were no signiﬁcant differences in kLIN,
tLIN, or kREL between native and exchanged myoﬁbrils (Table
1). In summary, the cTn exchange and the IANBD label on
cTnC appears not to alter signiﬁcantly the kinetics of contrac-
tion or relaxation of the myoﬁbrils.
In contrast to this, a decrease in the force per cross-
sectional area was observed in exchanged myoﬁbrils by up to
;1/3. A similar reduction of force upon cTn-exchange has
been reported for skinned ﬁbers (29,31).
We also determined the kinetics of ATP-induced cross-
bridge detachment of native and NBD-cTn exchanged myo-
ﬁbrils by measuring the changes in their intrinsic tryptophan
ﬂuorescence induced by mixing myoﬁbrils incubated under
rigor conditions with MgATP (32). The rate constant of the
ﬂuorescence increase induced by 1 mM MgATP for NBD-
cTn exchanged myoﬁbrils (32 6 7 s1, n ¼ 4) was not sig-
niﬁcantly different (p ¼ 0.30) from that for native myoﬁbrils
(466 11 s1, n¼ 4). In conclusion, neither the exchange nor
FIGURE 1 Incorporation of NBD-
cTn into guinea pig cardiac myoﬁbrils.
(A) Microscopic images (903 magniﬁ-
cation) in bright-ﬁeld (upper) and epi-
ﬂuorescencemode (lower) of a stretched
myoﬁbril bundle (consisting of two sin-
gle myoﬁbrils) exchanged with NBD-
cTn. The solid lines indicate the position
of a sarcomere limited by the twoZ-lines
and the dotted lines the position of the
thin ﬁlaments on both sides of a Z-line.
The width of solid lines corresponds to
the sarcomere length (3.15 mm). (B)
SDS-PAGE of guinea pig cardiac myo-
ﬁbrils (cMF) before and after the exchangewith humanNBD-cTn (for details, seeMaterials andMethods). Because endogenous guinea pig cTnC and exchanged
NBD-cTnC have the same electrophoretic mobility the incorporation was proved by excitation of NBD-cTn with ultraviolet light. To obtain high enough
ﬂuorescence, a 12-fold highermyoﬁbril- andNBD-cTn concentrationwas used than for cTnI and cTnT. (C) NBD-cTn exchangedmyoﬁbrils after beingmixed in
the stopped-ﬂow apparatus. (D)Myoﬁbrils exchangedwithNBD-cTnwere incubated either for 1 hwith 10mg/ml unlabeled cTn (‘‘chase’’) or in the same buffer
but without exogenous cTn (‘‘control’’). Thereafter, myoﬁbrils were washed in relaxation buffer (for further details, seeMaterials andMethods) and mixed with
either relaxation buffer (pCa .8) or activation buffer (pCa 4.6). Though the chased myoﬁbrils still exhibit a noticeable high basal ﬂuorescence at pCa .8,
the Ca21-induced ﬂuorescence increase is almost completely lost.
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the labeling changes fundamental kinetics properties of the
myoﬁbrils, although maximal force can be decreased.
To test whether the high shear forces during the stopped-
ﬂow measurements could damage the myoﬁbrils, we com-
pared the sarcomere length and morphology of the myoﬁbrils
before and after being mixed in the stopped-ﬂow apparatus:
no change in sarcomere length or in the morphology before
and after mixing of the myoﬁbrils could be detected even if
the maximum ﬂow rate of 14 ml/s was used (Fig. 1 C).
Switch-on kinetics of isolated NBD-cTn
and NBD-cTn incorporated into myoﬁbrils
In a ﬁrst series of experiments, we investigated whether the
structural environment of the myoﬁbrils changes the switch-
on kinetics of cTn. For this, we compared the Ca21-induced
ﬂuorescence increase of isolated and incorporated NBD-cTn
after changing the pCa from .8 to different pCa (Fig. 2, A
and E). In both isolated and incorporated cTn, the jump to
saturating [Ca21] induced a biphasic ﬂuorescence increase
with an initial fast phase that cannot be resolved (for details,
see below) followed by a resolvable slow phase. At Ca21
activation with pCa 4.6, the slow phase of the ﬂuorescence
increases monoexponentially with a rate constant of k1Caobs ¼
816 9 s1 (n ¼ 7) for isolated NBD-cTn and k1Caobs ¼ 3306
24 s1 (n ¼ 6) for incorporated NBD-cTn (Table 2). Thus,
incorporation of the NBD-cTn increased the kinetics of the
slow phase about fourfold at maximum Ca21 activation.
The kinetics of the fast phase of the ﬂuorescence increase
was too rapid to be resolved. The existence of the unre-
solvable fast phases with isolated and incorporated NBD-cTn
is clariﬁed in Fig. 2, A and E, respectively, where the mono-
exponential functions (black lines) ﬁtted to the ﬂuorescence
transients (gray lines) are extrapolated to t ¼ 0 s, i.e., the
time of mixing with Ca21. It is evident, that the extrapola-
tions do not reach the baseline levels obtained by mixing
isolated or incorporated NBD-cTn with the Ca21-free buffer
(pCa .8). After mixing isolated NBD-cTn with high [Ca21]
(pCa 4.6), already 50 6 5% (SD, n ¼ 5) of the total ﬂuores-
cence increase occurred within the dead time of 2.2 ms pro-
vided by the standard mixing cuvette of the apparatus (Fig.
2 A). For incorporated NBD-cTn, 63 6 14% (SD, n ¼ 6) of
the total ﬂuorescence increase could not be resolved (Fig. 2 E).
Even using a microcuvette with a shorter dead time of
;250 ms did not allow us to record the initial ﬂuorescence rise
(data not shown). Thus, the rate constant of the fast phase has
to be .2000 s1. This could be explained if the fast phase
represents the fast Ca21 binding to cTnC. We have supported
this hypothesis by modeling and simulation of the Ca21-
induced ﬂuorescence changes (for details, see Discussion).
The ﬂuorescence increase after activation with different
[Ca21] shows that the contribution of the fast phase to the
overall ﬂuorescence change is reduced with decreasing [Ca21]
(Fig. 2, B and F). At pCa ,6.0, almost the whole signal is
resolvable. This observation suggests that the fast phase and
the slow phase report two sequentially coupled conformational
changes (for details see Modeling, in Discussion) and thus
supports the hypothesis that the label senses the fast Ca21
binding to the regulatory Ca21-binding site II, which then in-
duces a slower, regulatory conformational change.
For isolated and incorporated NBD-cTn the Ca21 depen-
dencies of the steady-state ﬂuorescence amplitudes (DF) and
of the rate constants of the slow phase (k1Caobs ) can be ﬁtted by
sigmoidal dose-response curves (Fig. 2, C, D, G, and H). For
incorporated NBD-cTn, the Ca21 dependence of DF gives a
pCa50 of 6.46 0.1 (n¼ 6) (Table 2) and a Hill slope of 1.16
0.1 (n ¼ 6), whereas the Ca21 dependence of k1Caobs leads to a
pCa50 of 5.96 0.1 (n¼ 6) and a Hill slope of 2.36 0.4 (n¼ 6).
In comparison to this, the Ca21 dependence of DF of isolated
NBD-cTn has a pCa50 of 6.76 0.1 (n ¼ 5) and thus is ;0.3
pCa units higher than incorporated NBD-cTn. As expected,
the Hill slope is 1.0 6 0.1 (n ¼ 5). The Ca21 dependence of
the rate constant k1Caobs has a pCa50 of 6.2 6 0.1 (n ¼ 5) and
thus is also;0.3 pCa units higher than incorporated NBD-cTn.
The Hill slope is 1.4 6 0.4 (n ¼ 5).
Switch-off kinetics of NBD-cTn in myoﬁbrils
after Ca21 reduction
The kinetics of the conformational changes after Ca21 re-
moval from cTnC was determined also with isolated NBD-
cTn and NBD-cTn incorporated into myoﬁbrils. For this, the
isolated NBD-cTn or the exchanged myoﬁbrils were ﬁrst
Ca21-activated for 91 ms at pCa 5.0 and then inactivated at
pCa .8. The activation time was chosen to be sufﬁciently
long to reach steady-state ﬂuorescence during activation and,
on the other hand, to be sufﬁciently short to prevent over-
contraction of the myoﬁbrils.
Fig. 3, A and B, shows that after the reduction in [Ca21], the
ﬂuorescence decays biphasically for isolated and incorporated
TABLE 1 Force kinetics during activation and relaxation of exchanged and native myoﬁbrils
Activation Relaxation
Force/CSA (nN/mm2) kact(s
1) klin(s
1) tlin(s) krel(s
1)
Native myoﬁbrils 101 6 15 (5) 1.1 6 0.1 (11) 0.6 6 0.1 (11) 0.2 6 0.1 (11) 3.4 6 0.1 (11)
NBD-cTn exchanged myoﬁbrils 62 6 8 (7) 1.0 6 0.1 (24) 0.4 6 0.1 (24) 0.3 6 0.1 (24) 3.1 6 0.1 (24)
kact is the rate constant of force contraction, and klin, tlin, and krel describe kinetic parameters of force relaxation. For details, see text. Values given indicate the
mean 6 SE, with the number of experiments given in parentheses.
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NBD-cTn. As for the switch-on kinetics, the ﬁrst, fast phase
cannot be resolved and is followed by a second slower phase.
Compared to the switch-on kinetics, the amplitude of the
missed signal for incorporated NBD-cTn comprises only
286 15% (n¼ 10) of the total amplitude. For isolated NBD-
cTn the missed signal is 406 14% (n ¼ 5). The decay of the
slow phase was ﬁtted by a monoexponential yielding a rate
constant of kCaobs ¼ 396 2 s1 (n ¼ 10) for incorporated
NBD-cTn and kCaoff ¼ 286 3 s1 (n ¼ 5) for isolated
NBD-cTn.
Fig. 3 C shows the ﬂuorescence change of NBD-cTn after
mixing rigor myoﬁbrils with 1 mM ATP. The ﬂuorescence
FIGURE 2 Ca21 dependence of ﬂuorescence increase of
isolated (A and B) and incorporated (C and D) NBD-cTn.
(A) Fluorescence traces (gray lines) obtained after mixing
isolated NBD-cTn (in relaxation buffer, pCa.8) at t ¼ 0 s
with activation buffer, leading to pCa 4.6. The ﬁrst 2.2ms of
the traces cannot be shown because of the dead time of the
stopped-ﬂow instrument. The ﬂuorescence trace at pCa 4.6
was ﬁtted by a monoexponential function (solid lines) with
the ﬁt extrapolated to ‘‘negative’’ time. This emphasizes
that within the dead time a very rapid ﬂuorescence increase
has to occur that precedes the signal, which can be ﬁtted. (B)
Same as A, but with NBD-cTn mixed with activation buf-
fers, leading to different pCas. (C) Ca21 dependence of the
total ﬂuorescence amplitude of isolatedNBD-cTn. Symbols
and error bars show means 6 SE from ﬁve different pre-
parations. The line shows a sigmoidal dose-response curve
ﬁtted to the averaged data. Corresponding ﬁts of individual
data from each of ﬁve preparations resulted in a pCa50 of
6.7 6 0.1 and a nH of 1.0 6 0.1 (mean 6 SE). (D) Ca
21
dependence of the rate constant (k1Caobs ) of the slow phase.
k1Caobs data were ﬁtted as described for DF in B to yield a
pCa50 of 6.26 0.1 and a nH¼ 1.46 0.4 (n¼ 5). (E) Same as
A, but with NBD-cTn incorporated into myoﬁbrils. The
dotted line shows a biexponential simulation of the ﬂuo-
rescence increase, as shown in Fig. 6 A. The arrows indicate
the signal amplitude of the fast phase (DFfast) and of the
slow phase (DFslow). (F) Same as B, but with NBD-cTn
incorporated into myoﬁbrils. (G) Same as C, but data are
from six different myoﬁbrillar preparations, resulting in a
pCa50 of 6.46 0.1 and a nH of 1.16 0.1 (mean6 SE). (H)
Same as D, but with data from six different myoﬁbril-
lar preparations, resulting in a pCa50 of 5.9 6 0.1 and a
nH ¼ 2.36 0.4 (n ¼ 6).
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decays with a rate constant of 336 7 s1 (n¼ 3) and is similar
to the kCaobs ¼ 396 2 s1 after Ca21 inactivation.
Force kinetics of Ca21-dependent contraction/
relaxation of myoﬁbrils
To ﬁnd out whether the kinetics of the Ca21-dependent switch-
on/switch-off of cTn rate-limit the dynamics of myoﬁbrillar
force development and/or relaxation, force kinetics of myo-
ﬁbrils exchanged with NBD-cTn after rapid (within;10 ms)
changes in [Ca21] were determined in the mechanical setup.
Fig. 4 A depicts the Ca21-induced force development after a
change in pCa from .8 to 4.6. Force rises in a monoex-
ponential manner with a rate constant kACT ¼ 1.0 6 0.1 s1
(n¼ 24). Thus, at saturating [Ca21] the force develops;300-
fold slower than the slow phase of the ﬂuorescence increase,
which is presumed to reﬂect the regulatory conformational
change of cTnC.
Fig. 4 B shows that the force decay after the Ca21removal
(changing pCa from 4.6 to .8) is faster than force devel-
opment and, additionally, biphasic. First, during the ‘‘quasi-
isometric’’ slow phase, the sarcomere lengthening is negligible.
The rate constant of this slow phase is kLIN ¼ 0.4 6 0.1 s1
(n ¼ 24) and has a duration of tLIN ¼ 0.3 6 0.1 s (n ¼ 24).
The slow phase is followed by a rapid relaxation phase, which
is induced by the rapid, sequential lengthening of sarcomeres
(10). It has a rate constant of kREL ¼ 3.1 s16 0.1 (n ¼ 24).
Thus kLIN is;80 times, and kREL;10 times, slower than the
ﬂuorescence decay presumed to report the regulatory confor-
mational change of cTn.
DISCUSSION
The biphasic Ca21-induced ﬂuorescence changes obtained
by selectively labeling Cys-84 in cTnC with IANBD reveals
two conformational changes. The kinetics of the fast phase
obtained here in cardiac myoﬁbrils is at least one order of
magnitude faster compared to those found in studies inves-
tigating kinetics of fast skeletal TnI or cTnC in skinned ﬁbers
(33,9). Thus, the kinetics of Ca21 binding to cTnC in the
sarcomere has to be very rapid, at least ;10-fold faster than
proposed previously. Consequently, our slow phase, which has
rate constants similar to those found in the two ﬁber studies,
reports a subsequent conformational change that is kineti-
cally distinguishable from Ca21 binding to cTnC. Furthermore,
our results imply that the kinetics of the slow conformational
change are increased by incorporation of NBD-cTn into the
sarcomere. Finally, this study elucidates the dynamics of thin-
ﬁlament inactivation after Ca21 dissociation from cTnC in a
contractile system. Comparison with force kinetics suggests
that intrinsic kinetic properties of cTnC rate-limit neither the
speed of cardiac myoﬁbrillar contraction nor that of relaxation.
Labeling of cTnC
cTnC contains two reactive cysteines, which can be labeled
Cys-35 and Cys-84. Cys-35 is located in the nonfunctional
Ca21-binding loop I. Labeling of Cys-35 does not sense the
conformational change in skinned ﬁbers (34) and in
myoﬁbrils (data not shown). To minimize structural distur-
bances by unnecessary labeling of site 35, we created a Cys-
35-Ser mutant, which allows selective labeling of Cys-84.
Cys-84 is located on the C-terminal end of helix D.
Structural studies show that in the presence of Ca21, helix
D interacts with helix 3 in the regulatory region of cTnI (35).
Several kinetic studies with isolated proteins (13,15,36) and
studies on cTnC in skinned ﬁbers performed under steady-
state conditions (34,37,38) indicate that ﬂuorescent probes
coupled covalently to Cys-84 sense Ca21-induced confor-
mational changes of cTnC.
FIGURE 3 Fluorescence changes af-
ter mixing of NBD-cTn with BAPTA or
MgATP. (A) Mixing of Ca21-activated
isolated NBD-cTn with BAPTA to in-
duce a rapid decrease in [Ca21] pCa from
5.0 to.8 causes an exponential ﬂuores-
cence decay (gray line). This signal was
ﬁtted with a monoexponential decay
(black line), yielding a rate constant of
kCaobs ¼ 29 s1: The black transient de-
picts theﬂuorescence baseline for steady-
state activation at pCa 5.0. To obtain
these baselines, NBD-cTn was mixed with the same buffers in which it was incubated before the mixing. (B) Same as A, but with NBD-cTn incorporated into
myoﬁbrils. The monoexponential ﬁt of the decay yielded a rate constant of kCaobs ¼ 35 s1: (C) Myoﬁbrils exchanged with NBD-cTn in rigor buffer (pCa.8) were
mixedwith rigor buffer includingATPto rapidly increase [MgATP] from0 to1mM.The rate constantof the observedmonoexponential ﬂuorescencedecay is 31 s1.
TABLE 2 Ca21 sensitivity and kinetic parameters of ﬂuorescence changes of isolated and incorporated cTn
DF(4.6) (%) pCa 4.6 pCa50 k
1Ca
obs ðs1Þ pCa 4.6 k1Caobs ðs1Þ pCa 6.6 kCaobs (s1)
Isolated NBD-cTn 57 6 3 (5) 6,7 6 0,1 (5) 81 6 9 (7) 24 6 3 (4) 28 6 3 (5)
Incorporated NBD-cTn 57 6 5 (6) 6,4 6 0,1 (6) 330 6 24 (6) 56 6 24 (6) 39 6 2 (10)
Values given indicate the mean 6 SE, with the number of experiments given in parentheses.
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Kinetics of conformational changes with isolated
and incorporated cTn
This study compares the kinetics of thin-ﬁlament regulation
of isolated and incorporated cTn for the ﬁrst time that we
know of by using the same labeling and experimental ap-
proach. The Ca21-induced kinetics with isolated NBD-cTn
(Fig. 2, A and B) exhibit the same phases as NBD-cTn
incorporated into myoﬁbrils (Fig. 2, E and F): a fast phase,
which was too rapid to be resolved by the stopped-ﬂow tech-
nique, followed by a slow phase. These two distinct phases
indicate that NBD located on Cys-84 of cTnC undergoes two
conformational changes. The fast change is either directly or
closely associatedwith Ca21 binding to cTnC, which then trig-
gers a subsequent slower change. Two distinct conformational
changes of cTnI have also been proposed from analysis of
the crystal structures of chicken cTnC (39). Ca21 binding
to the regulatory domain II of cTnC ﬁrst induces the opening
of the N-lobe of cTnC, which then triggers an interaction
with the regulatory helix 3 of cTnI.
Such a two-step mechanism has been also proposed for the
kinetics that occur after Ca21 removal from isolated chicken
cTnC by Hazard et al. (13). The authors showed that the rate
constant of Ca21 release from cTnC (700–800 s1 at 4C)
determined with a ﬂuorescent Ca21 chelator is about three-
fold faster than the conformational change (kCaobs ¼ 260 s1)
reported by the ﬂuorescent probe IAANS on Cys-84. That
the conformational change in Hazard’s study is much faster
compared to that given by the slow phase in our study (14 s1
at 10C for reconstituted human Tn complex) likely results
from the assembly of cTnCwith cTnI. This assembly is known
to decrease the rate constant of the conformational change by
a factor of 10–20 (15). In this study (15) of Dong et al., it has
also been shown that addition of cTnT to cTnI-cTnC labeled
at Cys-35 of cTnC with IAANS did not further change the
kinetics induced by Ca21 and Ca21 removal. Therefore, the
increased rate constant of the slow phase that we observed
when cTn was incorporated into the myoﬁbrils seems to be
most likely due to a slight weakening of TnC-TnI interac-
tions when the cTn complex is bound to actin in the myoﬁbrils.
The increase in kinetics for the myoﬁbril-incorporated,
compared to the isolated, cTn complex was similar (fourfold)
for both Ca21 activation and Ca21 inactivation. It is note-
worthy that if diffusion of Ca21 or BAPTA into the myoﬁl-
ament lattice were to limit kinetics, one would expect slower,
but not faster, kinetics in myoﬁbrils. The faster inactivation
of the incorporated complex is in qualitative agreement with
biochemical studies showing that the association of Tn with
actin and Tm to form reconstituted thin ﬁlaments accelerates
the off-kinetics of skeletal Tn (40) and cardiac Tn (17). The
fourfold faster kinetics in myoﬁbrils might be related to a
decrease in activation energy (;3.5 kJ/mol) for the switch-
on and the switch-off transition when cTn is incorporated in
its native environment.
In conclusion, the similar biphasic shapes and the similar
[Ca21] dependence of ﬂuorescence transients for cTn incor-
porated in myoﬁbrils and for isolated cTn indicate that their
kinetic mechanism is similar but their switch kinetics of cTnC
in situ and in vitro are different.
Implications of the fast phase for the kinetics
of Ca21 binding
That the fast phase represents the Ca21 binding is demon-
strated by the observation that mixing of isolated cTn and
cTn incorporated into myoﬁbrils with high [Ca21] induces
the fast phase, which increases the ﬂuorescence by ;60%
within the dead time of the stopped-ﬂow apparatus (2.2 ms)
(Fig. 2, A and E). This fast conformational change must oc-
cur with a rate constant of .2000 s1, because we were un-
able to resolve its kinetics at saturating [Ca21] even when the
dead-time was reduced to 250 ms by using a microcuvette
(data not shown) instead of the standard mixing cuvette. This
suggests, that at high [Ca21], Ca21 binding is too rapid
(.2000 s1) to be temporally resolved by stopped ﬂow and
only manifests itself in an offset of the initial ﬂuorescence
compared to the Ca21-free control. Ca21-binding could be
therefore almost diffusion-controlled, as proposed by studies
with isolated skeletal TnC (41). Different groups determined
a second-order rate constant for Ca21-binding (kB) to isolated
skeletal and cardiac TnC of 100–200 mM1 s1 (13,41–43).
FIGURE 4 Force kinetics of cardiac myoﬁbrils ex-
changed with NBD-cTn after rapid changes in [Ca21]. (A)
At t¼0 s, the [Ca21] pCawas increased from.8 to 4.6. The
Ca21-induced force development (gray transient) is ﬁtted
by a monoexponential function (black line), which gives a
rate constant of kACT of 0.7 s
1. (B) At t ¼ 0 s, the [Ca21]
was rapidly decreased from pCa 4.6 to pCa .8. The force
decay after the Ca21 reduction (gray transient) is ﬁtted by
a biphasic function (black line) that includes a linear and
an exponential term to obtain the three kinetic parameters
kLIN ¼ 0.35 s1, tLIN ¼ 0.38 s, and kREL ¼ 3.8 s1.
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This would yield a rate constant for Ca21 binding of kB 
2500–5000 s1 at pCa 4.6 assuming that kB increases linearly
with [Ca21] in a nonsaturating manner, as for a diffusion-
controlled reaction. Tikunova and Davis (44) showed that
cTnC mutants can bind Ca21 with even faster second-order
rate constants, which indicates that the mechanism of Ca21
binding may be not purely diffusion-controlled. Neverthe-
less, introducing a linear dependence of kB on [Ca
21] rela-
tion in a model simulation gives close agreement with our
data (see modeling chapter).
We note that our interpretation of Ca21-binding kinetics
from phases in the ﬂuorescence transients differs from those
in previous studies of Dong et al. (15) on isolated cTn, and
Bell et al. (9) on cTnC in skinned ﬁbers. In neither of those
studies did the authors notice a phase of similar fast kinetics.
Dong et al. probed the kinetics of cTn by labeling the Cys-35
of cTnC with IAANS. In their study, they interpreted the fast
phase to probe the mechanism of Ca21 binding, but with a
rate constant of 30–40 s1 at 4C—compared to our data—it
kinetically corresponds to our slow phase of 80 s1 at 10C
for the isolated cTn. Bell et al. (9) investigated the Ca21-
induced switch-on kinetics of rhodamine-labeled cTnC in
skinned trabeculae from guinea pig by ﬂuorescence polar-
ization. They found two kinetic phases, of which they sug-
gested that the ﬁrst is associated with Ca21 binding. Again,
the kinetics of their fast phase is similar to that of our slow
phase but not to that of our fast phase. Because they had to
use caged Ca21, they could neither activate at saturating [Ca21]
nor make a deﬁned Ca21 dependence. However, at ;2/3 of
maximum Ca21 activation, their rate constant is ;100 s1,
which correlates with a k1Caobs of the slow phase of 1186 29 s
1
(n ¼ 5) at 65 6 8% activation in our results for the incor-
porated cTn complex.
In conclusion, our fast phase represents the rapid confor-
mational changes either directly or closely associated with an
almost diffusion-limited Ca21-binding process, whereas the
fast phases observed by Dong et al. (15) and Bell et al. (9)
clearly occur after Ca21 binding. As the rate constants of the
fast phases in the studies of Dong et al. and Bell et al. show
striking similarities, in terms of magnitude and Ca21 depen-
dence, with that of our slow phase, for isolated and incorpo-
rated cTn, respectively, it seems very likely that all three refer
to the same global conformational change of the cTn complex.
Relation of thin ﬁlament activation kinetics in the
sarcomere to force development
Our slow phase indicates a ;100-fold faster switch-on of
cTnC compared to the kinetics of force development. The
fast phase in the Bell et al. study is also ;20-fold faster than
Ca21-induced force development. Thus from both studies,
it is evident that the conformational change of cTnC will
not rate-limit the time course of force development.
In addition, Bell et al. also detected a very slow phase,
which had a rate constant (1–5 s1) identical to that of the
simultaneously measured Ca21-induced force development.
This phase indicates that cross-bridge binding can activate
the thin ﬁlament beyond the level of activation induced by
Ca21 alone. Though we labeled the same site Cys-84 on
cTnC as Bell et al., we could not detect this phase. This might
be related to the absence of external load during myoﬁbrillar
contraction in our stopped-ﬂow experiments. It is likely that
during unloaded shortening only a few strongly bound cross-
bridges are attached to the thin ﬁlament (45). Thus, the contri-
bution of cross-bridges to the activation of the thin ﬁlament is
negligible under our conditions. Therefore, we cannot ex-
clude a possible feedback of cross-bridges on thin ﬁlament
activation under isometric contraction. Consistent with the
presence of such a positive feedback, Bell et al. found that the
Ca21 sensitivity of the overall ﬂuorescence signal during con-
traction in the presence of MgATP is markedly increased
compared to Ca21 sensitivity in the presence of the non-force-
generating nucleotide analog ADP-vanadate.
Brenner and Chalovich (33) studied the kinetics of thin-
ﬁlament activation probed by ﬂuorescence of NBD-labeled
troponin I in skinned rabbit psoas ﬁbers. Their approach dif-
fers from ours and Bell’s in that the [Ca21] was kept constant
and thin-ﬁlament kinetics were induced by changing cross-
bridge attachment via mechanical perturbation. Like Bell et al.,
they found that slow ﬂuorescence changes occurred in paral-
lel with cross-bridge reattachment during force development.
However, these ﬂuorescence changes only occurred at inter-
mediate Ca21-activating levels and amounted to ;20% of
the total change observed between relaxing and fully-Ca21-
activating conditions. As Brenner and Chalovich (33) found
no slow ﬂuorescence changes during force redevelopment
under high [Ca21], their results indicated that cycling cross-
bridges are able to additionally activate the thin ﬁlament at
partial Ca21 activation, whereas at saturating [Ca21], Ca21
alone is sufﬁcient to fully activate the thin ﬁlament. When
cross-bridge attachment was rapidly lowered by suddenly
turning from isometric to unloaded shortening, ﬂuorescence
changed much faster, monoexponentially, with rate constants
increasing from;10–15 s1 at partial Ca21 activation to 50–
80 s1 at full Ca21 activation. Taking into account the lower
temperature in their study (5C), these values are in good
agreement with those of the slow phase in our experiment
(10C), which increased from;20 s1 to 330 s1 with [Ca21].
In conclusion, based on the results of these three different
and complementary studies (ours and (9,29)), we propose
that Ca21 binding triggers two conformational changes, a
fast one, induced directly by the Ca21 binding, and a sub-
sequent slower one, which is the major conformational
change, involving at least TnC and TnI, and which is ;1–2
orders of magnitude faster than force-development kinetics.
Additional 10- to 100-fold slower changes in thin ﬁlament
activation are likely occurring during the formation of force-
generating cross-bridges, but these are not triggered by Ca21
binding and might be restricted to intermediate levels of Ca21
activation.
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Further evidence that the slow phase in this study rep-
resents a global change of the Tn complex is given by the
considerations about switch-off kinetics induced by Ca21-
independent relaxation from rigor (see below).
Kinetics of thin-ﬁlament inactivation in myoﬁbrils
The ﬂuorescence change after a rapid reduction of [Ca21]
from pCa ¼ 5.0 to pCa . 8 consists of a slow phase with a
rate constant of 39 6 2 s1 (n ¼ 10). Based on our mea-
surements, we cannot exclude the possibility that a minor fast
phase precedes the slow phase (for details, see Results). Such
a minor fast phase could also explain why the amplitude of
ﬂuorescence decay is smaller than expected, as determined
from the difference between the steady-state ﬂuorescence levels
at pCa . 8 and pCa ¼ 5.0.
The similar kinetics of the ﬂuorescence decay induced by
Ca21 removal and that induced by mixing rigor myoﬁbrils
with MgATP in the continuous absence of Ca21 suggest that
the conformational changes of cTnC are linked to the overall
state of the thin ﬁlament. As is generally accepted, rigor bridges
keep the thin ﬁlament in an activated state even in the ab-
sence of Ca21 (46). They do so by causing Tm to move back
to its off position, where it blocks the strong binding acto-
myosin interaction. That ATP-induced detachment of rigor
bridges triggers a conformational change of cTnC with rate
constants similar to those in the relaxation experiments sug-
gests that this movement of Tm is mediated from Tm via cTnT
and cTnI to cTnC. The slow conformational change induced
by Ca21 removal therefore not only represents the kinetics of
a local change in the regulatory domain of TnC but is likely
correlated to the kinetics of a global change of the thin ﬁla-
ment involving the regulatory move of Tm.
Relating the kinetics of the conformational change of
cTnC after Ca21 inactivation to the kinetics of force relax-
ation is of special interest to determine whether the intrinsic
kinetic properties of regulatory proteins determine the time
course of force relaxation. The kinetics of the conformational
changes of cTnC during inactivation is slower than during
activation. Contrary to this, the force kinetics of myoﬁbrillar
relaxation is faster than for activation and, furthermore, oc-
curs in two phases. The inital slow phase of myoﬁbrillar force
relaxation occurs when all sarcomeres remain isometric,
whereas during the subsequent fast phase, cross-bridge de-
tachment is accelerated by rapid lengthening of single sar-
comeres (21,26). Correlation of the ﬂuorescence decay with
the force decays show that the switch-off is completed within
the ﬁrst;150 ms of the slow, linear phase of the force decay
(Fig. 4 B). This indicates that the intrinsic switch-off kinetics
of cTnC is much faster than the time course of force relax-
ation.
Nevertheless, the coupling between the switch-off of the
thin ﬁlament and cross-bridge detachment during a physi-
ological relaxation under load remains poorly understood. It
remains difﬁcult to predict how the ﬂuorescence decay would
occur under the isometric conditions under which the me-
chanical experiments were performed. In contrast, in the
stopped-ﬂow experiments, relaxation is likely initiated from
very low levels of cross-bridge attachment because of the
unloaded contraction of myoﬁbrils preceding the Ca21
removal. Under such conditions, the regulatory move of Tm
to its off position is not allosterically inhibited by cross-bridges,
and the conformational change of inactivation presumably
occurs at a higher rate in most regulatory actin-Tm-cTn units
than under isometric conditions where many cycling cross-
bridges would be attached to actin. It has been shown that
myosin Apo-S1—which is used to mimic the effects of strongly
bound cross-bridges—decreases the rate of the switch-off of
skeletal Tn and cTn in reconstituted thin ﬁlaments (17). These
ﬁndings agree with structural and kinetic studies of regulated
acto-S1 (47,48), implying that a regulatory unit will only be
able to switch off after S1 detaches from it. If this also ap-
plies to cycling cross-bridges, Tn should switch off during
loaded relaxation at a rate limited by cross-bridge detach-
ment. Thus, even though the rate for the switch-off intrinsic
to cTn (kCaobs ) measured in the absence of cross-bridges is
much faster than the rate of cross-bridge detachment, switch-
off in the presence of cycling cross-bridges might be faster.
However, this causes a new problem: if cycling cross-bridges
are able to keep the thin ﬁlament activated even in the ab-
sence of Ca21, like rigor bridges or Apo-S1, why should relax-
ation occur at all?
Another possibility is that cycling cross-bridges, in con-
trast to Apo-S1, cannot permanently trap Tm in its on-posi-
tion. The reason for such a mechanism could be that, e.g., the
regulatory switch controls the probability of how many
myosin heads enter force-generating states, but it would not
control myosin heads, which already are generating force (as
described in the steric blocking hypothesis). The argument
for this is that cycling cross-bridges do not delay the kinetics
of the force decay in isometrically held cardiac and skeletal
myoﬁbrils. In particular, the kinetics of the force decay is not
altered if relaxation is initiated from different force levels of
the preceding contraction (10,21,49). High phosphate con-
centrations greatly reduce the duration of the slow phase of
force relaxation to ,10 ms (10), which is less than half the
time of the switch-off of cTn (t1/2 ¼ 18 ms) determined in
this study. This suggests that there might be alternative ways
of cross-bridge detachment by rapid backward cycling and it
emphasizes that cross-bridge kinetics are the main determi-
nants of cardiac myoﬁbrillar relaxation.
In summary, we can conclude from our data that the ki-
netics of conformational changes intrinsic to cTnC do not
rate-limit the kinetics of the force decay during myoﬁbrillar
relaxation. However, the results presented here do not ex-
clude the possibility that these changes could occur under
loaded conditions brieﬂy after the cross-bridge detachment,
if it is presumed that force-generating cross-bridges alloste-
rically hinder the switch-off. Future experiments using skinned
ﬁbers with incorporated ﬂuorescently labeled regulatory proteins
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and caged Ca21 chelators would help to elucidate the cou-
pling mechanism of thin ﬁlament inactivation and cross-
bridge detachment.
Modeling of cTn kinetics
The minimal model that accounts for the observation of a fast
and a slow phase in the ‘‘on’’ experiments is shown by the
three-state model (Scheme 1, upper), where kB is the second-
order rate constant of Ca21 binding, kD the rate constant of
Ca21 dissociation, and kon and koff the rate constants of reg-
ulatory switch-on and switch-off, respectively. As discussed
before, there are several reasons for us to assume that the
Tn  Ca21off -state will be generated with kinetics according
to a diffusion-limited, or approximately diffusion-limited,
binding reaction with a rate constant kB[Ca
21] 1 kD that
does not saturate at high [Ca21] (41). Consequently, the fast
conformational change would occur immediately with Ca21
binding, i.e., there is no subsequent isomerization step whose
kinetics can be distinguished from those of Ca21 binding.
We modeled the data in two steps: as a ﬁrst approxima-
tion, the kinetics of Ca21 binding and dissociation were
treated as a rapid equilibrium. In this case, when kD  koff
and kD  kon, the kinetic analysis can be simpliﬁed from a
three-state model to a two-state model, as shown in the lower
panel of Scheme 1. This approach has the advantage of
yielding initial estimates for kon and koff, irrespective of the
values for kD and kB. In this two-state model, ﬂuorescence
will increase monoexponentially depending on the rate
constant k1Caobs ¼ konðappÞ1 koff ; where kon(app) is an apparent
Ca21-dependent rate constant and koff is a ﬁxed, Ca
21-
independent rate constant with the same value as koff in the
three-state model. The amplitude of the ﬂuorescence change
(DF) will be proportional to kon(app)/(kon(app)1 koff). Deﬁning
DF and kon(app) at the highest [Ca
21] (pCa 4.6) as DF(4.6) and
kon(app 4.6), respectively, k
1Ca
obs relates to the ﬂuorescence
change according to the equation given in Poggesi et al. (3):
k
1Ca
obs ¼
koff
1 konðapp:4:6Þðkonðapp:4:6Þ1 koffÞ
DF
DFð4:6Þ
 : (1)
Therefore, the experimental data were plotted as k1Caobs versus
the corresponding relative ﬂuorescence change (DF/DF(4.6)),
and ﬁtted by Eq. 1 (Fig. 5). The parameter koff corresponds to
the value of the ﬁt curve at DF ¼ 0 and the parameter
kon(app,4.6) to its total increment from DF ¼ 0 to DF(4.6).
Fitting of six experimental k1Caobs  DF=DFð4:6Þ relations from
six different myoﬁbrillar preparations yields koff ¼ 36 6 5
s1 and kon(app,4.6) ¼ 326 6 37 s1 (n ¼ 6). It is noteworthy
that the koff value determined by this model is close to the
rate constants determined from the ﬂuorescent traces of
the ‘‘off’’ experiments (kCaobs ¼ 396 2 s1). Furthermore, the
curvature of the ﬁt function—which is not a free parameter
itself and only depends on the ratio of koff and kon(app,4.6)—
agrees closely with the experimentally determined data
shown in Fig. 5. Thus, the experimentally determined data
are described well by the two-state model. However, an
exception is seen at low Ca21 activations (low DF) at which
the experimentally determined k1Caobs values are signiﬁcantly
SCHEME 1 Three-state model for thin-ﬁlament kinetics and its simpli-
ﬁcation to a two-state model. For the meaning of the rate constants and their
calculation, see text.
FIGURE 5 Dependence of the rate constant of the observable slow ﬂuo-
rescence change (kobs) on the relative ﬂuorescence amplitude. The relative
amplitude of the total ﬂuorescence change (DF/DF(4.6)) was obtained by
normalizing the ﬂuorescence changes induced by the different [Ca21] to that
induced by pCa 4.6 (DF(4.6)) in the particular experiment. kobs-(DF/DF(4.6))
obtained at the same [Ca21]s were plotted as mean 6 SE (circles and error
bars). The solid line represents the kobs-(DF/DF(4.6)) dependence given by
Eq. 1 according to the two-state model using the parameter means koff ¼ 36
s1 and kon(app.4.6) ¼ 326 s1, which were obtained from the six individual
ﬁts to the six experiments (see text). The solid line represents the dependence
according to the three-state model to additionally specify the parameters for
Ca21 binding and dissociation (for details, see text).
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lower than the koff values determined by the ﬁt. This
indicates that the initial assumption that kD  kon for the
two-state model is not completely fulﬁlled and that at low
Ca21 activations, k1Caobs might be not solely determined by koff
but also indirectly by kD. By determining the eigenvalues of
the rate constants for the three-state model (Fig. 5, dotted
line), it can be shown that if the value of kD were lowered to
approach that of kon, then the kobs at low Ca
21 activations
would be reduced below the koff determined initially in the
approximation of the two-state model, e.g., when kD ¼ kon,
then k1Caobs ¼ 0:5koff at DF/DF(4.6) ¼ 0. Hence, by moving
from the two- to the three-state model, we could estimate kD
by keeping the values for kon and koff constant and changing
the value of kD to match the kobs at low Ca
21 activations. By
setting kD to 550 s
1, the eigenvalue of kobs in the DF/DF(4.6)
region from 0–20% is lowered to 20–25 s1, in better agree-
ment with the corresponding experimental data. This estimated
value of kD is in the same range as those for isolated human
cTnC found by other groups (483 s1 (50) and 1200 s1 (44)).
Considering the three-state model, the equilibrium disso-
ciation constant for Ca21-binding (kB) is deﬁned by
KD ¼ kD
kB
¼ EC50ðkon1 koffÞ
koff
; (2)
where EC50 is the [Ca
21] required to yield the half-maximal
ﬂuorescence change (DF). The value of EC50 ¼ 0.4 mM was
obtained from the pCa50 ¼ 6.4 of the experimentally deter-
mined DF-pCa relation shown in Fig. 2 G. The value of kon
in the three-state model refers to the value of kon(app) in the
two-state model at inﬁnite [Ca21], meaning that at 100%
Ca21 saturation of cTn they are the same. For ,100%
saturation, e.g., at pCa 4.6, their interdependence is:
kon ¼ konðapp:4:6ÞðkB½Ca
21 1 kDÞ
kB½Ca21 
with ½Ca21  ¼ 104:6 M:
(3)
Solving Eqs. 2 and 3 for the second-order rate constant for
Ca21 binding (kB) yields a value of 117 mM
1 s1. This is
similar to those determined in studies on isolated human
cTnC (100 mM1 s1 (50) and 170 mM1 s1 (43)). The
overall broad similarity of the values of kB and kD deduced
from our modeling of cTn kinetics in myoﬁbrils to those
reported for isolated cTn suggests that Ca21 binding/dis-
sociation kinetics are primarily determined by cTnC and are
hardly altered by cTnC-cTnI interactions or by integration of
the cTn complex into the thin ﬁlament of myoﬁbrils. This
contrasts with the large changes in the kinetics of the regu-
latory switch, which are, as discussed above, slowed down
;10-fold by interaction of cTnC with cTnI (15), and ac-
celerated around fourfold by integration of the cTn complex
to myoﬁbrils.
The value of kon in the three-state model can be calculated
from Eq. 3: at pCa 4.6, the pseudo-ﬁrst-order rate constant of
Ca21 binding (kB[Ca
21]) is 2.900 s1. With kD ¼ 550 s1
and kon(app,4.6) ¼ 326 s1, it follows that kon ¼ 387 s1. This
is slightly higher than the kon(app,4.6), because a small fraction
of cTn (;1.6% of all cTnC states or 16% among the two
cTn off-states) will not have bound Ca21 at pCa 4.6.
It is noteworthy that in the three-state model, though kon
and koff are ﬁxed (Ca
21-independent) rate constants that do
not directly rate-limit the regulatory switch, the observed
kinetics of the regulatory switch are rate-modulated by the
Ca21-binding/dissociation step. As kB[Ca
21] is altered in
relation to kD, the observed rate constant of the regulatory
switch increases from values below koff at inﬁnitesimal
[Ca21] to koff1 kon at inﬁnite [Ca
21]. In this way, the Ca21-
dependent rapid binding/dissociation equilibrium affects the
observed rates of the switch kinetics.
A further implication of the model is that the Ca21
sensitivity of the regulatory switch (EC50 in Eq. 2) is
different from the Ca21 afﬁnity given by the Ca21-binding/
dissociation reaction (KD in Eq. 2). KD is the [Ca
21] at which
kB[Ca
21] ¼ kD, so that the equilibrium constant for the
Ca21-binding/dissociation step is unity. At [Ca21]¼ KD, the
two off-states (cTnoff and cTn*offCa21) are equally occupied,
i.e., half of them have bound Ca21. Thus, KD is an indicator
for the Ca21 afﬁnity of cTn if we would just focus on the
isolated Ca21-binding/dissociation reaction, i.e., as de-
termined without the regulatory switch. Indeed, without the
regulatory switch, half-maximal Ca21 binding would occur
at [Ca21] ¼ KD. However, due to the coupling to the
regulatory switch, the;10-fold faster on- than off-transition
of the regulatory switch shifts half-maximal Ca21-binding
from KD to EC50 according to Eq. 2. This kinetic coupling
might explain why the Ca21 afﬁnity of cTnCcTnI has been
found to be about an order of magnitude higher than for iso-
lated cTnC (51): when cTnI is absent, the regulatory switch
on cTnC may not occur and Ca21 afﬁnity of cTnC remains
low, being similar to KD in our model. When cTnI is present,
Ca21 binds to the N-lobe of cTnC to switch it on, and
because the equilibrium constant for the regulatory switch is
high (kon/koff  10), Ca21 binding is promoted. The high
ratio of kon/koff basically relates to our ﬁnding that the ki-
netics of the slow conformational change was strongly Ca21-
dependent, i.e., kobs increased .10-fold from low to high
[Ca21]. This also implicates a high fractional occupancy of
Ca21-activated sites: e.g., at pCa 4.6, in the steady state,
most of cTnC (;90%) will be switched on and only ;10%
will remain switched off (see Fig. 6 C).
To prove the correctness of the three-state model and its
kinetic parameters, we correlated the experimentally deter-
mined traces against the traces we obtained by simulating the
three-state model (Fig. 6, A and B). By appropriate setting of
relative ﬂuorescence for the three states, 100% for Tnoff,
135% for Tn*offCa21, and 170% for Tn  Ca21on ; close
agreement with experimental traces is obtained. A striking
feature of the simulated traces is that not only do they repro-
duce the kinetics of the experimentally determined traces,
but also the complex Ca21 dependence of the contribution of
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fast and slow phases to the amplitude of the ﬂuorescence
change, i.e., the fast phase contributes signiﬁcantly to the
signal only at high [Ca21] (pCa,6) (for illustration of DFfast
and DFslow, see also Figs. 2 E and 6 C). The fast phase is
generated by the formation of the Tn*offCa21 intermediate
state. Redistribution to this state is already rapid at low
[Ca21] due to the high kD, but a fast phase is not apparent at
low [Ca21] because of the low steady-state concentration of
this state. This steady-state concentration never exceeds 10%
of total cTn, even at very high [Ca21] (Fig. 6 C). The real
reason for the large fast phase at high [Ca21] is a transient
overshoot of the Tn  Ca21off state whose concentration
transiently rises above its steady-state level (Fig. 6 C). This
overshoot comes up when kB[Ca
21] . kon and can become
very large (e.g., sevenfold higher than its steady-state value
at pCa 4.6). This transient kinetic phenomenon can therefore
explain the observation that with increasing [Ca21] the
amplitude of the fast phase increases much more than the
amplitude of the slow phase. The good reproduction of this
observation by the model simulation (Fig. 6 B) is further
proof that the ﬂuorescence signals report two sequentially
coupled processes. If, for example, fast and slow phases
simply belong to two independent processes of fast and
slower kinetics, their amplitudes should rise in proportion to
each other when the [Ca21] is increased.
In conclusion, conformational changes of cTnC in its
sarcomeric environment involve rapid Ca21 binding and dis-
sociation kinetics, which are similar fast as has been reported
for isolated cTnC and a slower conformational change.
Several lines of evidence suggest that the slow conforma-
tional change represents the kinetics of the regulatory switch.
The Ca21-controlled rates at which cTnC switches on and
off are about two and one order of magnitude too fast to
directly rate-limit cardiac myoﬁbrillar contraction and re-
laxation, respectively. However, the results presented here
cannot fully exclude the possibility that higher numbers
of force-generating cross-bridges attached to actin during
loaded contraction-relaxation cycles induce additional regu-
latory changes of regulatory proteins that modulate the force
transient. Whether force-generating cross-bridges exert a
feedback on the dynamics of thin ﬁlament activation and in-
activation in loaded ﬁbers/myoﬁbrils remains to be resolved.
The authors thank Tom Barman (Institut national de la sante´ et de la
recherche me´dicale (INSERM), Montpellier, France) for his critical reading
of the manuscript and F. P. Kulozik for technical assistance.
This work was supported by grants from the Center of Molecular Medicine
Cologne (grant: TV91), Ko¨ln Fortune (Faculty of Medicine, Cologne, grant
109/2003), and, in part, by the Deutsche Forschungsgemeinschaft (SFB
612-A2).
REFERENCES
1. Kobayashi, T., and R. J. Solaro. 2005. Calcium, thin ﬁlaments, and the
integrative biology of cardiac contractility. Annu. Rev. Physiol. 67:
39–67.
2. Smith, D. A., and M. A. Geeves. 2003. Cooperative regulation of
myosin-actin interactions by a continuous ﬂexible chain II: actin-
tropomyosin-troponin and regulation by calcium. Biophys. J. 84:3168–
3180.
FIGURE 6 Ca21-induced ﬂuorescence signals predicted
by the three-state model involving Ca21 binding and a
subsequently coupled conformational change. (A) Simu-
lated time course of ﬂuorescence after instantaneous rises
in [Ca21] at t ¼ 0 s to different pCa (indicated by the
numbers). Kinetic parameters used for simulations were
kB¼ 117mM1 s1, kD¼ 550 s1, kon¼ 387 s1, and koff¼
36 s1 (for details, see text). The dotted line at 2.2 ms
represents the dead time of the apparatus. (B) Same as in A,
but with the ﬁtted, experimentally determined transients to
compare with the simulated curves predicted by the three-
state model parameters. (C) Time courses of the transient
fractional occupancies of the two Ca21-binding states
induced by different pCas. At high [Ca21], the transient of
the Tn*offCa21 state (black traces) exceeds its steady state,
which produces the large fast phase of the ﬂuorescence
increase depicted in A. The accumulation of the Tn*onCa21
state (gray traces) is the major determinant of the
observable slow phase after the dead time. (D) The
experimentally determined total ﬂuorescence increase in
dependence of the activating pCa is compared with the
theoretically determined total ﬂuorescence increase pre-
dicted by the three-state model (black line).
Troponin Switch Kinetics 3929
Biophysical Journal 93(11) 3917–3931
3. Poggesi, C., C. Tesi, and R. Stehle. 2005. Sarcomeric determinants of
striated muscle relaxation kinetics. Pﬂugers Arch. 449:505–517.
4. Backx, P. H., W. D. Gao, M. D. Azan-Backx, and E. Marban. 1995.
The relationship between contractile force and intracellular [Ca21] in
intact rat cardiac trabeculae. J. Gen. Physiol. 105:1–19.
5. Janssen, P. M., L. B. Stull, and E. Marban. 2002. Myoﬁlament
properties comprise the rate-limiting step for cardiac relaxation at body
temperature in the rat. Am. J. Physiol. Heart Circ. Physiol. 282:H499–
H507.
6. Palmer, S., and J. C. Kentish. 1994. The role of troponin C in mod-
ulating the Ca21 sensitivity of mammalian skinned cardiac and skel-
etal muscle ﬁbres. J. Physiol. 480:45–60.
7. Palmer, S., and J. C. Kentish. 1998. Roles of Ca21 and crossbridge
kinetics in determining the maximum rates of Ca21 activation and
relaxation in rat and guinea pig skinned trabeculae. Circ. Res. 83:
179–186.
8. Martin, H., M. G. Bell, G. C. Ellis-Davies, and R. J. Barsotti. 2004.
Activation kinetics of skinned cardiac muscle by laser photolysis of
nitrophenyl-EGTA. Biophys. J. 86:978–990.
9. Bell, M. G., E. B. Lankford, G. E. Gonye, G. C. Ellis-Davies, D. A.
Martyn, M. Regnier, and R. J. Barsotti. 2006. Kinetics of cardiac thin-
ﬁlament activation probed by ﬂuorescence polarization of rhodamine-
labeled troponin C in skinned guinea pig trabeculae. Biophys. J. 90:
531–543.
10. Stehle, R., M. Kruger, and G. Pﬁtzer. 2002. Force kinetics and
individual sarcomere dynamics in cardiac myoﬁbrils after rapid Ca21
changes. Biophys. J. 83:2152–2161.
11. Piroddi, N., A. Belus, B. Scellini, C. Tesi, G. Giunti, E. Cerbai,
A. Mugelli, and C. Poggesi. 2006. Tension generation and relaxation in
single myoﬁbrils from human atrial and ventricular myocardium.
Pﬂugers Arch. 454:63–73.
12. Johnson, J. D., S. C. Charlton, and J. D. Potter. 1979. A ﬂuorescence
stopped ﬂow analysis of Ca21 exchange with troponin C. J. Biol.
Chem. 254:3497–3502.
13. Hazard, A. L., S. C. Kohout, N. L. Stricker, J. A. Putkey, and J. J.
Falke. 1998. The kinetic cycle of cardiac troponin C: calcium binding
and dissociation at site II trigger slow conformational rearrangements.
Protein Sci. 7:2451–2459.
14. Strasburg, G. M., P. C. Leavis, and J. Gergely. 1985. Troponin-C-
mediated calcium-sensitive changes in the conformation of troponin I
detected by pyrene excimer ﬂuorescence. J. Biol. Chem. 260:366–370.
15. Dong, W. J., C. K. Wang, A. M. Gordon, S. S. Rosenfeld, and H. C.
Cheung. 1997. A kinetic model for the binding of Ca21 to the regu-
latory site of troponin from cardiac muscle. J. Biol. Chem. 272:19229–
19235.
16. Shitaka, Y., C. Kimura, T. Iio, and M. Miki. 2004. Kinetics of the
structural transition of muscle thin ﬁlaments observed by ﬂuorescence
resonance energy transfer. Biochemistry. 43:10739–10747.
17. Davis, J. P., C. Norman, T. Kobayashi, R. J. Solaro, D. R. Swartz, and
S. B. Tikunova. 2007. Effects of thin and thick ﬁlament proteins on
calcium binding and exchange with cardiac troponin C. Biophys. J. 92:
3195–3206.
18. Gordon, A. M., E. Homsher, and M. Regnier. 2000. Regulation of
contraction in striated muscle. Physiol. Rev. 80:853–924.
19. Ma, Y. Z., and E. W. Taylor. 1994. Kinetic mechanism of myoﬁbril
ATPase. Biophys. J. 66:1542–1553.
20. Lionne, C., M. Brune, M. R. Webb, F. Travers, and T. Barman. 1995.
Time resolved measurements show that phosphate release is the rate
limiting step on myoﬁbrillar ATPases. FEBS Lett. 364:59–62.
21. Tesi, C., N. Piroddi, F. Colomo, and C. Poggesi. 2002. Relaxation
kinetics following sudden Ca21 reduction in single myoﬁbrils from
skeletal muscle. Biophys. J. 83:2142–2151.
22. Kruger, M., G. Pﬁtzer, and R. Stehle. 2003. Expression and puriﬁcation
of human cardiac troponin subunits and their functional incorporation
into isolated cardiac mouse myoﬁbrils. J. Chromatogr. B Analyt.
Technol. Biomed. Life Sci. 786:287–296.
23. Brenner, B., T. Kraft, L. C. Yu, and J. M. Chalovich. 1999. Thin
ﬁlament activation probed by ﬂuorescence of N-((2-(iodoacetoxy)
ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1, 3-diazole-labeled troponin I
incorporated into skinned ﬁbers of rabbit psoas muscle. Biophys. J. 77:
2677–2691.
24. Herrmann, C., C. Lionne, F. Travers, and T. Barman. 1994. Correlation
of ActoS1, myoﬁbrillar, and muscle ﬁber ATPases. Biochemistry.
33:4148–4154.
25. Lane, L. C. 1978. A simple method for stabilizing protein-sulfhydryl
groups during SDS-gel electrophoresis. Anal. Biochem. 86:655–664.
26. Stehle, R., M. Kruger, P. Scherer, K. Brixius, R. H. Schwinger, and
G. Pﬁtzer. 2002. Isometric force kinetics upon rapid activation and
relaxation of mouse, guinea pig and human heart muscle studied on the
subcellular myoﬁbrillar level. Basic Res. Cardiol. 97(Suppl 1):I127–
I135.
27. Colomo, F., S. Nencini, N. Piroddi, C. Poggesi, and C. Tesi. 1998.
Calcium dependence of the apparent rate of force generation in single
striated muscle myoﬁbrils activated by rapid solution changes. Adv.
Exp. Med. Biol. 453:373–381.
28. Morimoto, S., H. Nakaura, F. Yanaga, and I. Ohtsuki. 1999. Functional
consequences of a carboxyl terminal missense mutation Arg278Cys in
human cardiac troponin T. Biochem. Biophys. Res. Commun. 261:
79–82.
29. Neulen, A., N. Blaudeck, S. Zittrich, D. Metzler, G. Pﬁtzer, and
R. Stehle. 2007. Mn21-dependent protein phosphatase 1 enhances pro-
tein kinase A-induced Ca21 desensitisation in skinned murine myo-
cardium. Cardiovasc. Res. 74:124–132.
30. She, M., D. Trimble, L. C. Yu, and J. M. Chalovich. 2000. Factors
contributing to troponin exchange in myoﬁbrils and in solution.
J. Muscle Res. Cell Motil. 21:737–745.
31. Takahashi-Yanaga, F., S. Morimoto, K. Harada, R. Minakami,
F. Shiraishi, M. Ohta, Q. W. Lu, T. Sasaguri, and I. Ohtsuki. 2001.
Functional consequences of the mutations in human cardiac troponin I
gene found in familial hypertrophic cardiomyopathy. J. Mol. Cell.
Cardiol. 33:2095–2107.
32. Stehle, R., C. Lionne, F. Travers, and T. Barman. 2000. Kinetics of the
initial steps of rabbit psoas myoﬁbrillar ATPases studied by tryptophan
and pyrene ﬂuorescence stopped-ﬂow and rapid ﬂow-quench. Evidence
that cross-bridge detachment is slower than ATP binding. Biochem-
istry. 39:7508–7520.
33. Brenner, B., and J. M. Chalovich. 1999. Kinetics of thin ﬁlament
activation probed by ﬂuorescence of N-((2-(iodoacetoxy)ethyl)-N-
methyl)amino-7-nitrobenz-2-oxa-1, 3-diazole-labeled troponin I incor-
porated into skinned ﬁbers of rabbit psoas muscle: implications for
regulation of muscle contraction. Biophys. J. 77:2692–2708.
34. Putkey, J. A., W. Liu, X. Lin, S. Ahmed, M. Zhang, J. D. Potter, and
W. G. Kerrick. 1997. Fluorescent probes attached to Cys 35 or Cys 84
in cardiac troponin C are differentially sensitive to Ca21-dependent
events in vitro and in situ. Biochemistry. 36:970–978.
35. Takeda, S., A. Yamashita, K. Maeda, and Y. Maeda. 2003. Structure of
the core domain of human cardiac troponin in the Ca21-saturated form.
Nature. 424:35–41.
36. Dong, W. J., and H. C. Cheung. 1996. Calcium-induced conforma-
tional change in cardiac troponin C studied by ﬂuorescence probes
attached to Cys-84. Biochim. Biophys. Acta. 1295:139–146.
37. Johnson, J. D., J. H. Collins, S. P. Robertson, and J. D. Potter. 1980. A
ﬂuorescent probe study of Ca21 binding to the Ca21-speciﬁc sites of
cardiac troponin and troponin C. J. Biol. Chem. 255:9635–9640.
38. Putkey, J. A., H. L. Sweeney, and S. T. Campbell. 1989. Site-directed
mutation of the trigger calcium-binding sites in cardiac troponin C. J.
Biol. Chem. 264:12370–12378.
39. Li, Y., M. L. Love, J. A. Putkey, and C. Cohen. 2000. Bepridil opens
the regulatory N-terminal lobe of cardiac troponin C. Proc. Natl. Acad.
Sci. USA. 97:5140–5145.
40. Rosenfeld, S. S., and E. W. Taylor. 1985. Kinetic studies of calcium
binding to regulatory complexes from skeletal muscle. J. Biol. Chem.
260:252–261.
3930 Solzin et al.
Biophysical Journal 93(11) 3917–3931
41. Johnson, J. D., R. J. Nakkula, C. Vasulka, and L. B. Smillie. 1994.
Modulation of Ca21 exchange with the Ca21-speciﬁc regulatory sites
of troponin C. J. Biol. Chem. 269:8919–8923.
42. Davis, J. P., J. A. Rall, P. J. Reiser, L. B. Smillie, and S. B. Tikunova.
2002. Engineering competitive magnesium binding into the ﬁrst
EF-hand of skeletal troponin C. J. Biol. Chem. 277:49716–49726.
43. Davis, J. P., J. A. Rall, C. Alionte, and S. B. Tikunova. 2004. Muta-
tions of hydrophobic residues in the N-terminal domain of troponin
C affect calcium binding and exchange with the troponin C-troponin
I96–148 complex and muscle force production. J. Biol. Chem. 279:
17348–17360.
44. Tikunova, S. B., and J. P. Davis. 2004. Designing calcium-sensitizing
mutations in the regulatory domain of cardiac troponin C. J. Biol.
Chem. 279:35341–35352.
45. Stehle, R., and B. Brenner. 2000. Cross-bridge attachment during high-
speed active shortening of skinned ﬁbers of the rabbit psoas muscle:
implications for cross-bridge action during maximum velocity of ﬁla-
ment sliding. Biophys. J. 78:1458–1473.
46. Lehman, W., R. Craig, and P. Vibert. 1994. Ca21-induced tropomyosin
movement in Limulus thin ﬁlaments revealed by three-dimensional
reconstruction. Nature. 368:65–67.
47. McKillop, D. F., and M. A. Geeves. 1993. Regulation of the interaction
between actin and myosin subfragment 1: evidence for three states of
the thin ﬁlament. Biophys. J. 65:693–701.
48. Vibert, P., R. Craig, and W. Lehman. 1997. Steric-model for activation
of muscle thin ﬁlaments. J. Mol. Biol. 266:8–14.
49. Stehle, R., M. Kruger, and G. Pﬁtzer. 2003. Does cross-bridge activa-
tion determine the time course of myoﬁbrillar relaxation? Adv. Exp.
Med. Biol. 538:469–479.
50. Brenkelmann, D., J. D. Potter, and P. R. Housmans. 2002. Effects of
volatile anesthetics on kinetics of conformational changes after Ca21
dissociation from human recombinant cardiac troponin C. Biophys. J.
82:387a. (Abstr.)
51. Niederer, S. A., P. J. Hunter, and N. P. Smith. 2006. A quantitative
analysis of cardiac myocyte relaxation: a simulation study. Biophys. J.
90:1697–1722.
Troponin Switch Kinetics 3931
Biophysical Journal 93(11) 3917–3931
